Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Device and procedure for producing a cellular pharmaceutical product enriched in genetically modified target cells at the bedside or in a surgical room

Device and procedure for producing a cellular pharmaceutical product enriched in genetically modified target cells at the bedside or in a surgical room

US Patent 11499976 · Granted Nov 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for manufacturing a patient specific cell population using a multifunctio2025
Method for manufacturing a patient specific cell population using a multifunctio2025
Method for manufacturing a patient specific cell population using a multifunctio2025
Method for manufacturing a patient specific cell population using a multifunctio2025
Method for manufacturing a patient specific cell population using a multifunctio2025
Method for manufacturing a patient specific cell population using a multifunctio2025
Method for manufacturing a patient specific cell population using a multifunctio2025
Compositions and methods for treating cancer with DuoCARs2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
Sterile connector2025
Sterile connector2025
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hemat2025